Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2073

1.

Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer.

Auchus RJ, Yu MK, Nguyen S, Mundle SD.

Oncologist. 2014 Oct 31. pii: theoncologist.2014-0167. [Epub ahead of print] Review.

PMID:
25361624
[PubMed - as supplied by publisher]
2.

[Roles of medical oncologists in the new era of CRPC therapy in Japan].

Takahashi S.

Gan To Kagaku Ryoho. 2014 Jul;41(7):827-31. Japanese.

PMID:
25131868
[PubMed - indexed for MEDLINE]
3.

Muscle and bone effects of androgen deprivation therapy: current and emerging therapies.

Cheung AS, Zajac JD, Grossmann M.

Endocr Relat Cancer. 2014 Oct;21(5):R371-94. doi: 10.1530/ERC-14-0172. Epub 2014 Jul 23.

PMID:
25056176
[PubMed - in process]
4.

The bifunctional role of steroid hormones: implications for therapy in prostate cancer.

Mathew P.

Oncology (Williston Park). 2014 May;28(5):397-404. Review.

PMID:
25004653
[PubMed - indexed for MEDLINE]
Free Article
5.

Targeting the androgen receptor in prostate cancer.

Culig Z.

Expert Opin Pharmacother. 2014 Jul;15(10):1427-37. doi: 10.1517/14656566.2014.915313. Epub 2014 Jun 2. Review.

PMID:
24890318
[PubMed - indexed for MEDLINE]
6.

Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.

Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA.

Cancer. 2014 Sep 1;120(17):2735-41. doi: 10.1002/cncr.28769. Epub 2014 May 19.

PMID:
24842808
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Prognostic significance of mutually exclusive expression of ERG and SPINK1 in endocrine-treated prostatic cancer].

Teng L, Gao W, Lu D, Xu J, Zhao L.

Zhonghua Bing Li Xue Za Zhi. 2014 Mar;43(3):149-53. Chinese.

PMID:
24842011
[PubMed - indexed for MEDLINE]
8.

Medical hypothesis: loss of the endocrine function of the prostate is important to the pathophysiology of postprostatectomy erectile dysfunction.

Kacker R, Morgentaler A, Traish A.

J Sex Med. 2014 Aug;11(8):1898-902. doi: 10.1111/jsm.12574. Epub 2014 May 16. Review.

PMID:
24836599
[PubMed - indexed for MEDLINE]
9.

The role of vitamin D in reducing cancer risk and progression.

Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ.

Nat Rev Cancer. 2014 May;14(5):342-57. doi: 10.1038/nrc3691. Epub 2014 Apr 4. Review.

PMID:
24705652
[PubMed - indexed for MEDLINE]
10.

Is high-dose leuprorelin acetate effective and safe in asian men with prostate cancer? An open-label, non-comparative, multi-center clinical trial.

Lee SH, Lee HM, Kim SW, Lee ES, Hong SJ, Kim CS, Kang TW, Chung BH.

Yonsei Med J. 2014 Mar;55(2):310-5. doi: 10.3349/ymj.2014.55.2.310.

PMID:
24532497
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA.

Radiat Oncol. 2014 Feb 4;9:44. doi: 10.1186/1748-717X-9-44.

PMID:
24495815
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Management of bone metastases].

Nagykálnai T, Landherr L.

Orv Hetil. 2014 Feb 9;155(6):217-25. doi: 10.1556/OH.2014.29781. Review. Hungarian.

PMID:
24486845
[PubMed - indexed for MEDLINE]
Free Article
13.

Design, synthesis and structure-activity relationships studies on the D ring of the natural product triptolide.

Xu H, Tang H, Feng H, Li Y.

ChemMedChem. 2014 Feb;9(2):290-5. doi: 10.1002/cmdc.201300409. Epub 2013 Dec 11.

PMID:
24339424
[PubMed - indexed for MEDLINE]
14.

[Neuroendocrine differentiation in prostate adenocarcinoma].

Ramírez-Balderrama L, López-Briones S, Daza-Benítez L, Macías MH, López-Gaytán T, Pérez-Vázquez V.

Gac Med Mex. 2013 Nov-Dec;149(6):639-45. Review. Spanish.

PMID:
24276187
[PubMed - indexed for MEDLINE]
15.

Male hypogonadism.

Basaria S.

Lancet. 2014 Apr 5;383(9924):1250-63. doi: 10.1016/S0140-6736(13)61126-5. Epub 2013 Oct 10. Review.

PMID:
24119423
[PubMed - indexed for MEDLINE]
16.

[Research activities on hormonal agents - focusing on kisspeptin and reproductive functions].

Matsui H.

Nihon Yakurigaku Zasshi. 2013 Oct;142(4):150-5. Review. Japanese. No abstract available.

PMID:
24107517
[PubMed - indexed for MEDLINE]
17.

TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.

Nyquist MD, Li Y, Hwang TH, Manlove LS, Vessella RL, Silverstein KA, Voytas DF, Dehm SM.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17492-7. doi: 10.1073/pnas.1308587110. Epub 2013 Oct 7.

PMID:
24101480
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer.

Leinonen KA, Saramäki OR, Furusato B, Kimura T, Takahashi H, Egawa S, Suzuki H, Keiger K, Ho Hahm S, Isaacs WB, Tolonen TT, Stenman UH, Tammela TL, Nykter M, Bova GS, Visakorpi T.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2333-44. doi: 10.1158/1055-9965.EPI-13-0333-T. Epub 2013 Oct 1.

PMID:
24083995
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Intensity-modulated radiotherapy combined with endocrine therapy for intermediate and advanced prostate cancer: long-term outcome of Chinese patients.

Luo HC, Cheng HH, Lin GS, Fu ZC, Li DS.

Asian Pac J Cancer Prev. 2013;14(8):4711-5.

PMID:
24083731
[PubMed - indexed for MEDLINE]
Free Article
20.

[Treatable and untreatable forms of recurrent prostate cancer].

Ueda T, Kobayashi M, Komaru A, Fukazawa K, Akakura K.

Gan To Kagaku Ryoho. 2013 Aug;40(8):998-1002. Japanese.

PMID:
23986043
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk